All Stories

  1. Relationships among host genetics, gut microbiota, and asthma in US Hispanic/Latino adults
  2. Modeling the genomic architecture of adiposity and anthropometrics across the lifespan
  3. A multi-ethnic polygenic risk score for chronic kidney disease is associated with increased risk of hypertension in African American individuals
  4. Ancestry Calibration of Polygenic Risk Scores Improves Risk Stratification and Effect Estimation in African American Adults
  5. Type 2 Diabetes Polygenic Risk Score Interactions with Lifestyle Risk Factors in Black Americans
  6. Alterations in DNA Methylation, Proteomic, and Metabolomic Profiles in African Ancestry Populations with APOL1 Risk Alleles
  7. Epigenome-wide association study meta-analysis of BMI in African American Adults
  8. Machine learning‐based clustering identifies obesity subgroups with differential multi‐omics profiles and metabolic patterns
  9. EXPLANA: A user-friendly workflow for EXPLoratory ANAlysis and feature selection in cross-sectional and longitudinal microbiome studies
  10. Poly-omic risk scores predict inflammatory bowel disease diagnosis
  11. Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review
  12. Multi-ancestry genome-wide study identifies effector genes and druggable pathways for coronary artery calcification
  13. The Microbiome, Epigenome, and Diet in Adults with Obesity during Behavioral Weight Loss
  14. Human microbiome transfer in the built environment differs based on occupants, objects, and buildings
  15. Poly-omic risk scores predict inflammatory bowel disease diagnosis
  16. Characterization of the gut microbiota among Veterans with unique military-related exposures and high prevalence of chronic health conditions: A United States-Veteran Microbiome Project (US-VMP) study
  17. Associations of Nutrient Intake Changes During Childhood with Adolescent Hepatic Fat: The Exploring Perinatal Outcomes Among CHildren Study
  18. The Gut Microbiota during a Behavioral Weight Loss Intervention
  19. Genetic risk for type 2 diabetes and metabolic health among youth
  20. Genetic Interactions with Intrauterine Diabetes Exposure in Relation to Obesity: The EPOCH and Project Viva Studies
  21. Soluble CD14 Levels in the Jackson Heart Study: Associations With Cardiovascular Disease Risk and Genetic Variants
  22. Multiomic Predictors of Short‐Term Weight Loss and Clinical Outcomes During a Behavioral‐Based Weight Loss Intervention
  23. Dietary habits and the gut microbiota in military Veterans: results from the United States-Veteran Microbiome Project (US-VMP)
  24. Microbial Diversity and Community Structures Among Those With Moderate to Severe TBI: A United States-Veteran Microbiome Project Study
  25. Feasibility of collection and analysis of microbiome data in a longitudinal randomized trial of community gardening
  26. Genetic Risk for Hepatic Fat among an Ethnically Diverse Cohort of Youth: The Exploring Perinatal Outcomes among Children Study
  27. Variation in contrast-associated acute kidney injury prophylaxis for percutaneous coronary intervention: insights from the Veterans Affairs Clinical Assessment, Reporting, and Tracking (CART) program
  28. Development and Validation of a Semi-Automated Surveillance Algorithm for Cardiac Device Infections: Insights from the VA CART program
  29. Novel methodology to measure pre-procedure antimicrobial prophylaxis: integrating text searches with structured data from the Veterans Health Administration’s electronic medical record
  30. Gut microbiota phenotypes of obesity
  31. Real-world effectiveness of infection prevention interventions for reducing procedure-related cardiac device infections: Insights from the veterans affairs clinical assessment reporting and tracking program
  32. Reply to Moossavi and Azad, “Quantifying and Interpreting the Association between Early-Life Gut Microbiota Composition and Childhood Obesity”
  33. Contemporary use of intra-aortic balloon pumps during percutaneous coronary intervention
  34. Military-Related Exposures, Social Determinants of Health, and Dysbiosis: The United States-Veteran Microbiome Project (US-VMP)
  35. Gestational weight gain charts for different body mass index groups for women in Europe, North America, and Oceania
  36. Gut Microbiota in the First 2 Years of Life and the Association with Body Mass Index at Age 12 in a Norwegian Birth Cohort
  37. Prolonged antimicrobial prophylaxis following cardiac device procedures increases preventable harm: insights from the VA CART program
  38. Maggie Stanislawski—August ECI biocommentary
  39. The implications of cocaine use and associated behaviors on adverse cardiovascular outcomes among veterans: Insights from the VA Clinical Assessment, Reporting, and Tracking (CART) Program
  40. Gut microbiome of mothers delivering prematurely shows reduced diversity and lower relative abundance of Bifidobacterium and Streptococcus
  41. Sex Differences in 1-Year Outcomes After Percutaneous Coronary Intervention in the Veterans Health Administration
  42. The Microbiome in Posttraumatic Stress Disorder and Trauma-Exposed Controls: An Exploratory Study
  43. Variation in Management of Patients With Obstructive Coronary Artery Disease: Insights From the Veterans Affairs Clinical Assessment and Reporting Tool (VA CART) Program
  44. Pre-pregnancy weight, gestational weight gain, and the gut microbiota of mothers and their infants
  45. Coronary atherectomy is associated with improved procedural and clinical outcomes among patients with calcified coronary lesions: Insights from the VA CART program
  46. Contemporary Incidence, Management, and Long-Term Outcomes of Percutaneous Coronary Interventions for Chronic Coronary Artery Total Occlusions
  47. Association Between Chronic Kidney Disease and Rates of Transfusion and Progression to End‐Stage Renal Disease in Patients Undergoing Transradial Versus Transfemoral Cardiac Catheterization—An Analysis From the Veterans Affairs Clinical Assessment Repo...
  48. Use of Contraindicated Antiplatelet Medications in the Setting of Percutaneous Coronary Intervention
  49. Cardiac Electrophysiology Laboratories: A Potential Target for Antimicrobial Stewardship and Quality Improvement?
  50. Association of Borderline Pulmonary Hypertension With Mortality and Hospitalization in a Large Patient Cohort: Insights From the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program
  51. Nonobstructive Coronary Artery Disease and Risk of Myocardial Infarction
  52. Patient Access and 1-Year Outcomes of Percutaneous Coronary Intervention Facilities With and Without On-Site Cardiothoracic Surgery
  53. Safety and Effectiveness of Drug-Eluting Versus Bare-Metal Stents in Saphenous Vein Bypass Graft Percutaneous Coronary Interventions
  54. Invasive coronary procedure use and outcomes among veterans with posttraumatic stress disorder: Insights from the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program
  55. Normal Coronary Rates for Elective Angiography in the Veterans Affairs Healthcare System
  56. Adoption of Transradial Percutaneous Coronary Intervention and Outcomes According to Center Radial Volume in the Veterans Affairs Healthcare System